glp-1 receptor agonist type 1 diabetes randomized trial Clinical efficacy results from clinical trials comparing different The predicted impact of GLP‐1

True lactose intolerance usually presents itself as diarrhea

Six compounds

Combination Approaches Future treatments might combine incretin agonists with other weight loss mechanisms like metabolism boosters, appetite suppressants working through non-incretin pathways, or fat absorption inhibitors

extract standardisation used in positive trials is a critical variable [3, 12] Stress amplifies tinnitus significantly, HPA axis dysregulation drives auditory cortex hypervigilance [4] The gutbrainear axis is underutilised

doi: 10.1111/dom.14174 65 HartmanMLSanyalAJLoombaRWilsonJMNikooienejadABrayRet al

Leptins have previously failed in obesity studies, but there could be potential in exploring combination therapies